×

Impedimed Limited

Founded and headquartered in Brisbane, Australia, ImpediMed is a global company with operations in the United States and Europe. We are the world leader in the design and manufacture of medical devices employing bioimpedance spectroscopy (BIS) technologies for use in the noninvasive clinical assessment and monitoring of fluid status and tissue composition.

Spotlight Videos

News

ASX rallies 0.55% as Energy outperforms

19 Jul 2023 - The Energy sector demonstrated strong growth, with a rally of 1.7%. Ampol (ASX:ALD) experienced a significant surge of 4.4% following robust fuel sale volumes reported for the first half of the financial year 2023. At the closing bell, the S&P/ASX 200 was 0.55 per cent higher at 7,323.70.

Read More